6 Results for "

BTG2

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "BTG2" in MCE Product Catalog:

Cat. No.: HY-RS01663
Research Areas:  

Others

BTG2 Human Pre-designed siRNA Set A contains three designed siRNAs for BTG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS20698
Research Areas:  

Others

Btg2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Btg2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS27209
Research Areas:  

Others

Btg2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Btg2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
loading...
    loading...
Cat. No.: HY-P88133
Synonyms: APRO1; PC3; TIS21

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P88133A
Synonyms: APRO1; PC3; TIS21

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-187035
CAS No.: 868066-26-6
Target:  

CDK STAT

Research Areas:  

Cancer

SNX631 is an orally active and selective CDK8/CDK19 inhibitor. SNX631 reduces the phosphorylation of STAT1/STAT3 S727, and upregulates miR-21-5p, miR-21-3p and miR-221 in cancer cells. SNX631 transcription-independently inhibits meiotic resumption in mouse oocytes, blocks nuclear envelope breakdown, first polar body extrusion and mitochondrial expansion and aggregation, with no cytotoxicity. SNX631, in combination with Lapatinib (HY-50898) or Trastuzumab (HY-P9907), synergistically inhibits cancer cell growth, upregulates the tumor suppressor BTG2, prevents Lapatinib-induced upregulation of oncogenic miRNAs, overcomes drug resistance, reduces the infiltration of αSMA+ stromal fibroblasts and ARG1+ M2 macrophages, and exhibits favorable biosafety. SNX631 can be used in studies related to HER2-positive breast cancer and cancer [2] .
loading...
    loading...